Improving intestinal and digestive comfort

IbSium® is a game changer in the field of gastrointestinal symptoms management. Recent clinical results confirmed that daily administration of this patented and proprietary probiotic yeast (S.cerevisiae CNCM I-3856) may alleviate occasional abdominal pain and improve the quality of life of IBS (Irritable Bowel Syndrome) subjects .
Gnosis by Lesaffre
key figure
96% satisfaction reported on more than 1,160 volunteers.

For hundreds of millions of people around the world, gastrointestinal symptoms significantly impact their quality of life on a daily basis. Simple pleasures such as going out to dinner, practicing sports or spending time with friends are spoiled by debilitating abdominal pain, bloating, or transit disorders such as diarrhea and constipation. To live with these symptoms, many embark on a complex medical journey with multiple solutions in search of relief.

IbSium® (Saccharomyces cerevisiae CNCM I-3856), a unique probiotic yeast developed by Gnosis by Lesaffre, introduces a new way to alleviate these symptoms. Four clinical studies have shown that this strain may not only significantly alleviate occasional gastrointestinal symptoms but may also improve overall quality of life (reduce food avoidance, improve body image, lessen interference with activities).

Beyond its efficacy, this breakthrough probiotic yeast strain does not need to be refrigerated and offers a three-year shelf life.

IbSium® is the result of real teamwork and collaboration over the past 10 years, which has allowed us to build the science behind this ingredient.

To find out more on IbSium®, click here.

With its published clinical efficacy, IbSium® is truly a gold standard probiotic yeast that supports complete digestive comfort.
Digestion & Gut Health Market Manager